Medicine liquid for treating onychomycosis, and preparation method and application thereof

A technology of onychomycosis and medicinal liquid, applied in the field of medicinal liquid for treating onychomycosis and its preparation, which can solve the problems of uncurable gray finger (toe) nail, cumbersome treatment process, and lack of compliance, so as to make up for various defects , broad application prospects, no toxic and side effects

Inactive Publication Date: 2017-12-22
SHANGHAI YAOJIAN BIO TECH
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment mode of external medicine generally exists following obvious defect: the one, the treatment process is loaded down with trivial details, and the patient can not insist on completing the treatment process, just in the patient's treatment process, there is no compliance, thereby can't cure gray finger (toe) nail; It is the low efficiency of drug penetration and absorption, which is also a key factor affecting the treatment
The damage to the liver caused by oral systemic medication is not easy to avoid. Therefore, in fact, very few patients with onychomycosis are willing to use the above-mentioned related regimen for treatment. Therefore, t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine liquid for treating onychomycosis, and preparation method and application thereof
  • Medicine liquid for treating onychomycosis, and preparation method and application thereof
  • Medicine liquid for treating onychomycosis, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The medicinal liquid that present embodiment treats onychomycosis is made up of the following components of each weight percentage:

[0026] fungicide

[0027] Described bactericide is benzalkonium chloride. The javanica javanica oil was purchased from Baoji Senrui Biochemical Co., Ltd. The Phellodendron Phellodendri extract was purchased from Nanjing Zelang Biotechnology Co., Ltd. Described emulsifier is soybean lecithin.

Embodiment 2

[0029] The medicinal liquid that present embodiment treats onychomycosis is made up of the following components of each weight percentage:

[0030]

[0031]

[0032] Described bactericide is benzalkonium bromide. The javanica javanica oil was purchased from Baoji Senrui Biochemical Co., Ltd. The Phellodendron Phellodendri extract was purchased from Nanjing Zelang Biotechnology Co., Ltd. The emulsifier is dipalmitoylphosphatidylcholine.

Embodiment 3

[0034] The medicinal liquid that present embodiment treats onychomycosis is made up of the following components of each weight percentage:

[0035] fungicide

[0036] Described bactericide is chlorhexidine acetate. The javanica javanica oil was purchased from Baoji Senrui Biochemical Co., Ltd. The Phellodendron Phellodendri extract was purchased from Nanjing Zelang Biotechnology Co., Ltd. Described emulsifier is poloxamer 124.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to medicine liquid for treating onychomycosis, and a preparation method and application thereof. The medicine liquid consists of the following components in percentage by weight: 0.01 to 2.5 percent of fungicide, 0.01 to 1.0 percent of oleum fructus bruceae, 0.05 to 1.0 percent of golden cypress extract, 5 to 30 percent of glacial acetic acid, 0.005 to 0.5 percent of menthol, 0.01 to 1.0 percent of an emulsifier and the balance of water, wherein the fungicide is selected from one or more of benzalkonium chloride, benzalkonium bromide, chlorhexidine acetate and polyhexamethylene guanidine hydrochloride. The medicine liquid can remarkably kill escherichia coli, staphylococcus aureus and candida albicans, can effectively treat the onychomycosis, and has the advantages of safety, no toxic or side effect, rapid response, convenience and low cost.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicinal solution for treating onychomycosis, a preparation method and application thereof. Background technique [0002] Onychomycosis (toe) nail is a common name for fingernails or toenails caused by fungal infection, and it is medically called onychomycosis. This is a nail disease mainly caused by dermatophytes (mainly Trichophyton rubrum, accounting for about 85%), yeast and other fungal infections. Patients who suffer from tinea pedis for a long time, up to 50% can then infect and become gray finger (toe) nail. [0003] In the past, the treatment of onychomycosis (toe) nails was mainly based on external medication, oral systemic medication, softening and removing nails, and surgical nail removal. The typical treatment method of external medicine is: 1) first remove the diseased nail as much as possible with a knife or a nail file, then rub it with 30% glacial acetic ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/756A61P17/00A61P31/10A61P31/04A61K31/14A61K31/155A61K31/785A61K31/045
CPCA61K9/0014A61K31/045A61K31/14A61K31/155A61K31/785A61K36/185A61K36/756A61K2236/333A61K2236/35A61K2236/39A61K2236/51A61K2300/00Y02A50/30
Inventor 刘传伟王井光
Owner SHANGHAI YAOJIAN BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap